Cirrhosis is a condition in which the liver does not function properly due to long term damage. Typically, the disease comes on slowly over months or years. Cirrhosis is characterized by the replacement of normal liver tissue by scar tissue. Clusterin (apolipoprotein J) is a 75 -80 kDa disulfide-linked heterodimeric protein associated with the clearance of cellular debris and apoptosis.
Introduction
Cirrhosis is a condition in which the liver does not function properly due to longterm damage.This damage is characterized by the replacement of normal liver tissue by scar tissue. Typically, the disease develops slowly over months or years. Early on, there are often no symptoms. As the disease worsens, a person may become tired, weak, itchy, have swelling in the lower legs, develop yellow skin, bruise easily, have fluid build up in the abdomen, or develop spider-like blood vessels on the skin. 
Results of the study
This study was performed in Sohag University Hospital, on 20 patients known to have HCV ,in addition to 20 healthy individuals (age-and sex-matched). Data was analyzed using Statistical package for social sciences (IBM-SPSS), version 24 IBMChicago, USA (May 2016).Quantitative data was represented as mean, standard deviation, median and range. Data was analyzed using student t-test to compare means of two groups and ANOVA for comparison of the means of three groups or more. The mean age in group I is 53.2 years, SD 4.09 years and the range is (45 -62years), the mean age in group II is 53.8 years, SD 5.5 years and the range is (46 -66years). No significant difference was found in comparing diseased group with controls (P=0.77) as in figure (1). All subjects in the control group had normal liver biochemistry but in CHC group was significantly higher ( Table 1) . As expected, serum AFP (ng/ml) was significantly higher in the CHC patients compared to the control group. Serum CLU (ng/ml) level showed a significant decrease in the CHC group compared to the control group (  Table 2) . Table ( 1):Liver function tests in the studied groups Table ( 2):AFP and CLU in the studied groups
Discussion
According to WHO 2012, every year, 3-4 million people are infected with the hepatitis C virus. About 150 million people are chronically infected and at risk of developing liver cirrhosis and/or liver cancer. More than 350000 people die from hepatitis C-related liver diseases every year. AFP showed statistically significant elevation in group I LC patients as regard controls(P <0.01).The elevation of AFP occurs in hepatocyte regeneration, hepatocarcinogenesis, and embryonic carcinomas (Malaguarnera, 2010) . Serum CLU, Serum CLU showed a significant decrease in the LC group as regards controls. This may point to a possible protective role of CLU against liver cell fibrogenesis which ultimately ends in cirrhosis. Such an assumption was similarly postulated in renal 
Conclusion
CLU is decreased in the serum of patients with established CHC.
